Damien Bosc

584 total citations
18 papers, 308 citations indexed

About

Damien Bosc is a scholar working on Molecular Biology, Organic Chemistry and Epidemiology. According to data from OpenAlex, Damien Bosc has authored 18 papers receiving a total of 308 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Organic Chemistry and 6 papers in Epidemiology. Recurrent topics in Damien Bosc's work include Click Chemistry and Applications (7 papers), Chemical Synthesis and Analysis (6 papers) and Synthesis and Biological Evaluation (4 papers). Damien Bosc is often cited by papers focused on Click Chemistry and Applications (7 papers), Chemical Synthesis and Analysis (6 papers) and Synthesis and Biological Evaluation (4 papers). Damien Bosc collaborates with scholars based in France, Canada and United Kingdom. Damien Bosc's co-authors include Benoît Déprez, Rebecca Deprez‐Poulain, Joëlle Dubois, Elisabeth Mouray, Philippe Grellier, Ronan Gealageas, Florence Leroux, Robert N. Young, Nicolette S. Honson and Tom Pfeifer and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and Molecules.

In The Last Decade

Damien Bosc

18 papers receiving 307 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Damien Bosc France	11	166	152	68	43	24	18	308
Walajapet G. Rajeswaran United States	12	146 0.9×	174 1.1×	46 0.7×	45 1.0×	23 1.0×	19	375
Tummala Rama Krishna Reddy United Kingdom	9	264 1.6×	165 1.1×	24 0.4×	16 0.4×	21 0.9×	11	388
Kiyean Nam United States	11	115 0.7×	237 1.6×	77 1.1×	43 1.0×	29 1.2×	24	458
Brian Jones United States	10	107 0.6×	84 0.6×	38 0.6×	22 0.5×	41 1.7×	15	264
Christiane Guillouzo France	10	134 0.8×	163 1.1×	43 0.6×	30 0.7×	11 0.5×	10	437
Fernanda Aparecida Heleno Batista Brazil	14	38 0.2×	282 1.9×	52 0.8×	43 1.0×	14 0.6×	31	449
Gisela Backfisch Germany	11	123 0.7×	130 0.9×	29 0.4×	11 0.3×	13 0.5×	16	451
Peter J. Webb United States	14	92 0.6×	168 1.1×	104 1.5×	36 0.8×	19 0.8×	17	454
Nikhil Reddy Madadi United States	13	339 2.0×	195 1.3×	19 0.3×	60 1.4×	47 2.0×	26	550
Aaron Kosinski United States	12	77 0.5×	263 1.7×	67 1.0×	25 0.6×	10 0.4×	16	449

Countries citing papers authored by Damien Bosc

Since Specialization

Citations

This map shows the geographic impact of Damien Bosc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Damien Bosc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Damien Bosc more than expected).

Fields of papers citing papers by Damien Bosc

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Damien Bosc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Damien Bosc. The network helps show where Damien Bosc may publish in the future.

Co-authorship network of co-authors of Damien Bosc

This figure shows the co-authorship network connecting the top 25 collaborators of Damien Bosc. A scholar is included among the top collaborators of Damien Bosc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Damien Bosc. Damien Bosc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Wen, Xiaoan, Valérie Landry, Adrien Herlédan, et al.. (2021). Identification of indole-based activators of insulin degrading enzyme. European Journal of Medicinal Chemistry. 228. 113982–113982. 7 indexed citations

Lipka, Emmanuelle, et al.. (2021). Multi-component reaction for the preparation of 1,5-disubstituted 1,2,3-triazoles by in-situ generation of azides and nickel-catalyzed azide-alkyne cycloaddition. Tetrahedron Letters. 73. 153131–153131. 19 indexed citations

Déprez, Benoît, Damien Bosc, Julie Charton, et al.. (2021). Molecular Design in Practice: A Review of Selected Projects in a French Research Institute That Illustrates the Link between Chemical Biology and Medicinal Chemistry. Molecules. 26(19). 6083–6083. 2 indexed citations

Gealageas, Ronan, Catherine Piveteau, Julie Charton, et al.. (2020). Modulators of hERAP2 discovered by high-throughput screening. European Journal of Medicinal Chemistry. 211. 113053–113053. 10 indexed citations

Leroux, Florence, Damien Bosc, Terence Beghyn, et al.. (2019). Identification of ebselen as a potent inhibitor of insulin degrading enzyme by a drug repurposing screening. European Journal of Medicinal Chemistry. 179. 557–566. 13 indexed citations

Bosc, Damien, et al.. (2019). Kinetic Target-Guided Synthesis: Reaching the Age of Maturity. Journal of Medicinal Chemistry. 63(8). 3817–3833. 25 indexed citations

Bosc, Damien, Patrick Gizzi, Marcel Hibert, et al.. (2017). Comparative Study of the Synthesis and Structural and Physicochemical Properties of Diketopiperazines vs Aza-diketopiperazines. The Journal of Organic Chemistry. 82(6). 3239–3244. 7 indexed citations

Bosc, Damien, Catherine Piveteau, Ronan Gealageas, et al.. (2017). Controlling Plasma Stability of Hydroxamic Acids: A MedChem Toolbox. Journal of Medicinal Chemistry. 60(21). 9067–9089. 49 indexed citations

Bosc, Damien, et al.. (2016). Kinetic Target-Guided Synthesis in Drug Discovery and Chemical Biology: A Comprehensive Facts and Figures Survey. Future Medicinal Chemistry. 8(4). 381–404. 30 indexed citations

10.

Vezenkov, Lubomir, Nicolette S. Honson, Nag S. Kumar, et al.. (2015). Development of fluorescent peptide substrates and assays for the key autophagy-initiating cysteine protease enzyme, ATG4B. Bioorganic & Medicinal Chemistry. 23(13). 3237–3247. 33 indexed citations

11.

Bosc, Damien, Elisabeth Mouray, Sandrine Cojean, et al.. (2015). Highly improved antiparasitic activity after introduction of an N-benzylimidazole moiety on protein farnesyltransferase inhibitors. European Journal of Medicinal Chemistry. 109. 173–186. 13 indexed citations

12.

DeVorkin, Lindsay, Damien Bosc, Katharina Rothe, et al.. (2015). Precision autophagy: Will the next wave of selective autophagy markers and specific autophagy inhibitors feed clinical pipelines?. Autophagy. 11(10). 1949–1952. 15 indexed citations

13.

Bakali, Jamal El, Julie Dumont, Damien Bosc, et al.. (2013). Aggrecanase-2 inhibitors based on the acylthiosemicarbazide zinc-binding group. European Journal of Medicinal Chemistry. 69. 244–261. 16 indexed citations

14.

Bosc, Damien, Elisabeth Mouray, Philippe Grellier, et al.. (2013). Introduction of methionine mimics on 3-arylthiophene: influence on protein farnesyltransferase inhibition and on antiparasitic activity. MedChemComm. 4(6). 1034–1034. 6 indexed citations

15.

Bosc, Damien, et al.. (2012). New protein farnesyltransferase inhibitors in the 3-arylthiophene 2-carboxylic acid series: diversification of the aryl moiety by solid-phase synthesis. Journal of Enzyme Inhibition and Medicinal Chemistry. 28(1). 163–171. 26 indexed citations

16.

Bosc, Damien, et al.. (2012). Improvement of the trypanocidal activity of 3-arylthiophene farnesyltransferase inhibitors by modulation of their 3-aryl group. MedChemComm. 3(12). 1512–1512. 9 indexed citations

17.

Bosc, Damien & Alfred Galichon. (2010). Extreme Dependence for Multivariate Data. SSRN Electronic Journal. 1 indexed citations

18.

Bosc, Damien, et al.. (2009). Discovery of a New Class of Protein Farnesyltransferase Inhibitors in the Arylthiophene Series. Journal of Medicinal Chemistry. 52(20). 6205–6208. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact